Announcements Trials

Browse Landscape

Phase

Status

Active not recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Colorectal Neoplasms 2 Carcinoma, Non-Small-Cell Lung 2 Breast Neoplasms 2 Small Cell Lung Carcinoma 1 Sleep Wake Disorders 1 Prostatic Neoplasms 1 Precursor Cell Lymphoblastic Leukemia-Lymphoma 1 Multiple Myeloma 1 Melanoma 1 Malignant Solid Neoplasm 1 Malignant Primary Pelvic Neoplasm 1 Lymphoma, Non-Hodgkin 1 Lung Neoplasms 1 Leukemia, Lymphocytic, Chronic, B-Cell 1 Inflammatory Breast Neoplasms 1 Hodgkin Disease 1 Hematopoietic and Lymphatic System Neoplasm 1 Hematologic Neoplasms 1 Heart Defects, Congenital 1 Fatigue 1 Depression 1 Colonic Neoplasms 1 Clinical Stage I Esophageal Adenocarcinoma American Joint Committee on Cancer (AJCC) v8 1 Carcinoma, Merkel Cell 1 Anxiety Disorders 1 Anatomic Stage I Breast Cancer AJCC v8 1

Interventions

pembrolizumab 57 Nivolumab 50 Ipilimumab 31 Specimen Handling 23 Magnetic Resonance Spectroscopy 19 Cyclophosphamide 14 Biopsy 11 fludarabine 10 binimetinib 10 Opdualag 10 trametinib 9 relatlimab 9 Radiosurgery 9 CTLA-4 Antigen 9 dabrafenib 8 lifileucel 7 fludarabine phosphate 7 aldesleukin 7 encorafenib 6 Interleukin-2 6 cemiplimab 5 atezolizumab 5 Paclitaxel 5 Blood Specimen Collection 5 X-Rays 4 Taxes 4 Radiotherapy 4 Pemetrexed 4 Gemcitabine 4 Cisplatin 4

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Melanoma × Exercise Test × 90 days × Clear all

NCT06008977 2026-03-25

EX-BOOST

AdventHealth Translational Research Institute

Phase NA Active not recruiting

Melanoma, Carcinoma, Merkel Cell

Data powered by HemOnc (CC BY 4.0) Colophon ⚡